Current Medical Research and Opinion

Current Medical Research and Opinion Journal

Publication venue for

Payer formulary tier increases of apixaban: how patients respond and potential implications 2023
Payer formulary exclusions of apixaban: how patients respond and potential implications 2022
Impact of apixaban treatment discontinuation on the risk of hospitalization among patients with nonvalvular atrial fibrillation and COVID-19 2022
Rationale for a titratable fixed-ratio co-formulation of a basal insulin analog and a glucagon-like peptide 1 receptor agonist in patients with type 2 diabetes. 35:793-804. 2019
A real-world analysis of glycemic control among patients with type 2 diabetes treated with canagliflozin versus dapagliflozin. 34:1143-1152. 2018
Comparison of major bleeding risk in patients with non-valvular atrial fibrillation receiving direct oral anticoagulants in the real-world setting: a network meta-analysis. 34:487-498. 2018
The impact of non-medical switch on type 2 diabetes patients treated with canagliflozin in the commercially insured US population. 34:1501-1511. 2018
Comparison of effectiveness and safety of treatment with apixaban vs. other oral anticoagulants among elderly nonvalvular atrial fibrillation patients. 33:1745-1754. 2017
Risk of major bleeding in patients with non-valvular atrial fibrillation treated with oral anticoagulants: a systematic review of real-world observational studies. 33:1583-1594. 2017
An early evaluation of bleeding-related hospital readmissions among hospitalized patients with nonvalvular atrial fibrillation treated with direct oral anticoagulants. 32:573-582. 2016
Warfarin time in therapeutic range and its impact on healthcare resource utilization and costs among patients with nonvalvular atrial fibrillation. 32:87-94. 2016
Achievement of treatment goals with canagliflozin in patients with type 2 diabetes mellitus: a pooled analysis of randomized controlled trials. 31:1993-2000. 2015
Adherence to non-vitamin-K-antagonist oral anticoagulant medications based on the Pharmacy Quality Alliance measure. 31:2167-2173. 2015
Why is warfarin underused for stroke prevention in atrial fibrillation? A detailed review of electronic medical records. 28:1407-1414. 2012
Relationship between bone mass, invasive breast cancer incidence and raloxifene therapy in postmenopausal women with low bone mass or osteoporosis. 24:807-813. 2008

International Standard Serial Number (ISSN)

0300-7995